AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

CSL LIMITED

263.430

-1.280-0.48%

Volume:167.74K

Turnover:44.26M

Market Cap:127.55B

PE:29.10

High:265.300

Open:264.000

Low:262.230

Close:264.710

Loading ...

Overview Company News Filings

Australian shares decline, dragged by banks and miners, as Trump tariffs kick off

BRIEF-Csl Ltd Says CSL Seqirus & Esperion Sign Licensing Agreement

CSL Ltd - CSL Seqirus & Esperion Sign Licensing Agreement to Commercialise Nexletol and Nexlizetin Australia & New Zealand

THOMSON REUTERS

2 strong ASX 200 blue chip shares for your SMSF

Esperion Partners with CSL Seqirus to Commercialize NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) in Australia

5 high-quality ASX ETFs to buy in March

BMRN or CSLLY: Which Is the Better Value Stock Right Now?

Why did the ASX 200 go backwards in February?

BlackRock to reassess Australian exposure amid stretched valuations, weak growth

Large cap reporting season update: Defensive stocks doing well

BRIEF-CSL Says Swissmedic Approves Andembry To Prevent Recurrent Attacks Of Hereditary Angioedema

CSL Ltd - Swissmedic Approves CSL Behring’s Andembry (Garadacimab) for Prevention of Recurrent Attacks of Hereditary Angioedema

THOMSON REUTERS

CSL shares: Buy, sell or hold in 2025?

3 super strong ASX 200 blue chip shares to buy for your SMSF

Is Carlisle Companies Incorporated (NYSE:CSL) Trading At A 27% Discount?

Simply Wall St.

This week’s Hot Stock tip is perfect way to pounce on RBA cut – but have an exit plan too

The Market Herald

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CSL.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CSL.AU"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","market":"AU","secType":"STK","nameCN":"CSL LIMITED","latestPrice":263.43,"timestamp":1741137362138,"preClose":264.71,"halted":0,"volume":167742,"delay":0,"changeRate":-0.004835,"change":-1.28,"floatShares":483945244,"shares":484206716,"eps":9.051158,"lyrEps":8.742677,"pbRate":4.3,"amount":44258442.86,"amplitude":0.011598,"volumeRatio":0.455048,"dividePrice":4.395429,"prevYearClose":281.58,"fiveDayClose":264.82,"twentyDayClose":270.34},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","floatShares":483945244,"roa":"6.61%","roe":"14.35%","lyrEps":8.742677,"volumeRatio":0.455048,"shares":484206716,"dividePrice":4.395429,"high":265.3,"amplitude":0.011598,"preClose":264.71,"low":262.23,"week52Low":253.04,"pbRate":"4.30","psRate":"5.24","week52High":311.319,"institutionHeld":0,"latestPrice":263.43,"committee":0.080569,"eps":9.051157995684486,"divideRate":0.016809,"volume":167742,"delay":0,"ttmEps":9.051157995684486,"open":264,"prevYearClose":281.58,"prevWeekClose":260.57,"prevMonthClose":260.57,"prevQuarterClose":281.58,"fiveDayClose":264.82,"twentyDayClose":270.34,"sixtyDayClose":281.7},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CSL.AU\",params:#limit:5,,,undefined,":[{"date":"2025-03-10","symbol":"CSL.AU","amount":1.3,"announcedDate":"2025-02-11","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-03-11","defaultRemindTime":1741561200000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-09","payableDate":"2025-03-11","currency":"USD","dateTimestamp":1741525200000,"payDate":"2025-04-09"},{"date":"2025-02-11","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1739228400000,"name":null,"time":"","dateTimestamp":1739192400000,"actualEps":null},{"date":"2024-09-09","symbol":"CSL.AU","amount":1.45,"announcedDate":"2024-08-13","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2024-09-10","defaultRemindTime":1725840000000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-10-02","payableDate":"2024-09-10","currency":"USD","dateTimestamp":1725804000000,"payDate":"2024-10-02"},{"date":"2024-08-13","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723507200000,"name":null,"time":"","dateTimestamp":1723471200000,"actualEps":null},{"date":"2024-03-11","symbol":"CSL.AU","amount":1.19,"announcedDate":"2024-02-13","type":"dividend","market":"AU","newRecordDate":"2024-03-12","defaultRemindTime":1710111600000,"name":"CSL 公司","recordDate":"2024-04-03","payableDate":"2024-03-12","currency":"USD","dateTimestamp":1710075600000,"payDate":"2024-04-03"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CSL.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-10","recordDate":"2020-09-11","paymentDate":"2020-10-09","value":1.469578,"currency":"AUD"},{"executeDate":"2021-03-04","recordDate":"2021-03-05","paymentDate":"2021-04-01","value":1.04,"currency":"USD"},{"executeDate":"2021-09-02","recordDate":"2021-09-03","paymentDate":"2021-09-30","value":1.062,"currency":"USD"},{"executeDate":"2022-03-07","recordDate":"2022-03-08","paymentDate":"2022-04-06","value":1.04,"currency":"USD"},{"executeDate":"2022-09-06","recordDate":"2022-09-07","paymentDate":"2022-10-05","value":1.062,"currency":"USD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CSL.AU\",pageSize:16,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2516661278","title":"Australian shares decline, dragged by banks and miners, as Trump tariffs kick off","url":"https://stock-news.laohu8.com/highlight/detail?id=2516661278","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516661278?lang=en_us&edition=fundamental","pubTime":"2025-03-04 14:05","pubTimestamp":1741068324,"startTime":"0","endTime":"0","summary":"Australian shares decline, dragged by banks and miners, as Trump tariffs kick offUpdates to market closeAustralia's benchmark ASX200 slips 0.6% amid trade war fearsBanks fall 0.5%, miners fall 0.7%New Zealand benchmark falls 0.6%By Nikita Maria Jino","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nL3N3PN0D3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7135","BK7067","BK7501","NAB.AU","BK7095","BK7046","BK7511","BK7507","BK7508","BHP.AU","MQG.AU","CSL.AU"],"gpt_icon":0},{"id":"2516696895","title":"BRIEF-Csl Ltd Says CSL Seqirus & Esperion Sign Licensing Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2516696895","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516696895?lang=en_us&edition=fundamental","pubTime":"2025-03-04 09:01","pubTimestamp":1741050092,"startTime":"0","endTime":"0","summary":"BRIEF-Csl Ltd Says CSL Seqirus & Esperion Sign Licensing Agreement March 4 (Reuters) - CSL Ltd CSL.AX:CSL SEQIRUS & ESPERION SIGN LICENSING AGREEMENT TO COMMERCIALISE NEXLETOL AND NEXLIZET IN AUSTRALIA & NEW ZEALANDFurther company coverage: CSL.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nFWN3PM19B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7501","BK7067","BK7511","CSL.AU"],"gpt_icon":0},{"id":"2516695406","title":"CSL Ltd - CSL Seqirus & Esperion Sign Licensing Agreement to Commercialise Nexletol and Nexlizetin Australia & New Zealand","url":"https://stock-news.laohu8.com/highlight/detail?id=2516695406","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516695406?lang=en_us&edition=fundamental","pubTime":"2025-03-04 08:54","pubTimestamp":1741049681,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nFWN3PM19B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7501","BK7508","CSL.AU","BK7511"],"gpt_icon":0},{"id":"2516775657","title":"2 strong ASX 200 blue chip shares for your SMSF","url":"https://stock-news.laohu8.com/highlight/detail?id=2516775657","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516775657?lang=en_us&edition=fundamental","pubTime":"2025-03-04 02:37","pubTimestamp":1741027020,"startTime":"0","endTime":"0","summary":"If you are on the hunt for new additions to your self-managed super fund (SMSF), then it could pay to listen to what analysts at Bell Potter are saying about the shares in this article. The broker has","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/03/04/2-strong-asx-200-blue-chip-shares-for-your-smsf/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7501","BK7511","BK7044","BK7508","JHX.AU","BK7067","CSL.AU"],"gpt_icon":0},{"id":"2516633139","title":"Esperion Partners with CSL Seqirus to Commercialize NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) in Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2516633139","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516633139?lang=en_us&edition=fundamental","pubTime":"2025-03-03 21:00","pubTimestamp":1741006800,"startTime":"0","endTime":"0","summary":"– Esperion to Receive an Upfront Payment and Near-Term Milestones Along with a Profitable Transfer Price on Product Sales –。ANN ARBOR, Mich., March 03, 2025  -- Esperion Therapeutics  today announced it has entered into a license and distribution agreement with CSL Seqirus  for the exclusive rights to commercialize NEXLETOL  and NEXLIZET  in Australia and New Zealand. Under the terms of the agreement, Esperion will receive an upfront and near-term milestone payments and will be responsible for supplying finished product to CSL Seqirus at a profitable transfer price.\"We’re committed to helping reduce the burden of cardiovascular disease in Australia and New Zealand, and we are delighted to be working with Esperion to help make new treatment options available. These products are an important addition to CSL Seqirus' portfolio of in-licensed medicines,\" said Danielle Dowell, CSL Seqirus Executive Director of Commercial Operations Asia Pacific.NEXLETOL, in combination with other LDL-C lowe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/esperion-partners-csl-seqirus-commercialize-130000606.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ESPR","LU1169590202.USD","LU0728928796.USD","BK4086","SGXZ23171101.USD","CSL.AU","LU1169589451.USD","BK4007","CSL","SG9999004303.SGD"],"gpt_icon":0},{"id":"2516154781","title":"5 high-quality ASX ETFs to buy in March","url":"https://stock-news.laohu8.com/highlight/detail?id=2516154781","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516154781?lang=en_us&edition=fundamental","pubTime":"2025-03-03 04:24","pubTimestamp":1740947084,"startTime":"0","endTime":"0","summary":"For investors looking to diversify their portfolios and gain exposure to strong-performing sectors or indices, exchange-traded funds (ETFs) can be a great way to do it. That's because ASX ETFs offer a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/03/03/5-high-quality-asx-etfs-to-buy-in-march/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["ESmain","BK7016","BK4585","FDN","SSO","BK7095","UPRO","BK7067","SPY","CSL.AU","BK7501","VOO","WTC.AU","BK4559","BK7507","CBA.AU","ATEC.AU","BHP.AU","SPXU","XAO.AU","VAS.AU","BK4550","IVV.AU",".SPX","IVV","BK4504","BK7511","BK7508","XRO.AU","BK7135","ASIA.AU","SDS","BK4534","XJO.AU","OEF","XKO.AU","SH","BK4581","BK4588","MOAT.AU","BK7503","OEX"],"gpt_icon":0},{"id":"2516308887","title":"BMRN or CSLLY: Which Is the Better Value Stock Right Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2516308887","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516308887?lang=en_us&edition=fundamental","pubTime":"2025-03-01 00:40","pubTimestamp":1740760814,"startTime":"0","endTime":"0","summary":"Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both BioMarin Pharmaceutical  and CSL Limited Sponsored ADR . But which of these two stocks offers value investors a better bang for their buck right now?The best way to find great value stocks is to pair a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system. The proven Zacks Rank puts an emphasis on earnings estimates and estimate revisions, while our Style Scores work to identify stocks with specific traits.Currently, BioMarin Pharmaceutical has a Zacks Rank of #2 , while CSL Limited Sponsored ADR has a Zacks Rank of #4 . Investors should feel comfortable knowing that BMRN likely has seen a stronger improvement to its earnings outlook than CSLLY has recently. But this is just one piece of the puzzle for value investors.BioMarin Pharmaceutical Inc.  : Free Stock Analysis Report. CSL Limited Sponsored ADR  : Free Stock Analysis Report. This article orig","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bmrn-cslly-better-value-stock-164014485.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CSL.AU","BK4566","IE0002270589.USD","IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","CSLLY","IE00B19Z3581.USD","BMRN","BK4139"],"gpt_icon":0},{"id":"2514934053","title":"Why did the ASX 200 go backwards in February?","url":"https://stock-news.laohu8.com/highlight/detail?id=2514934053","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514934053?lang=en_us&edition=fundamental","pubTime":"2025-02-28 11:07","pubTimestamp":1740712025,"startTime":"0","endTime":"0","summary":"The S&P/ASX 200 Index(ASX: XJO) is down 0.7% in afternoon trade on Friday. Barring a last minute miracle, that means the benchmark Aussie index will have gone backwards over the month. The ASX 200 clo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/02/28/why-did-the-asx-200-go-backwards-in-february/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BHP.AU","BK7507","XJO.AU","BK7135","XKO.AU","XAO.AU","BK7508","BK7141","BK7067","BK7505","BK7095","BK7501","CSL.AU","CBA.AU","BK7511","A2M.AU"],"gpt_icon":0},{"id":"2514103338","title":"BlackRock to reassess Australian exposure amid stretched valuations, weak growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2514103338","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514103338?lang=en_us&edition=fundamental","pubTime":"2025-02-27 11:29","pubTimestamp":1740626993,"startTime":"0","endTime":"0","summary":"that 4% unemployment rate obviously is causing them a bit of consternation,\" said Craig Vardy, BlackRock's Australasia head of fixed income.That would reduce the prospect for more rate cuts to stimulate growth for Australia's households, he added.  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nL3N3PI06Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7135","LU1291159041.SGD","LU2430703178.SGD","LU0320765489.SGD","LU1201861249.SGD","LU0208291251.USD","LU1509826696.USD","LU1074936037.SGD","LU1670628061.USD","LU0772969993.USD","LU2430703095.HKD","BK4534","BHP.AU","IE00BVYPNW00.USD","LU2592432038.USD","BK4533","BK7501","BK7507","CSL.AU","IE00B64PRP62.GBP","IE00BDGV0183.EUR","LU1599440770.SGD","BLK","BK7067","LU0731783394.SGD","LU2264538146.SGD","LU1280957306.USD","BK4535","BK4581","LU0640476718.USD","LU1670627923.USD","CBA.AU","IE00B3PB1722.GBP","BK7511","LU0980610538.SGD","BK7095","LU1481011911.USD","BK7508","IE00BGHQF631.EUR","LU0742537680.HKD","BK4567","IE00BVYPNV92.GBP","BK4504","LU2505996509.AUD","LU1481011671.HKD","BK4588","LU0130102774.USD","LU0731783048.USD","IE00BGHQF748.EUR","BK4135"],"gpt_icon":1},{"id":"2514672815","title":"Large cap reporting season update: Defensive stocks doing well","url":"https://stock-news.laohu8.com/highlight/detail?id=2514672815","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514672815?lang=en_us&edition=fundamental","pubTime":"2025-02-27 10:01","pubTimestamp":1740621677,"startTime":"0","endTime":"0","summary":"In our latest reporting season coverage, I discuss how investors have been rotating away from momentum-driven stocks with high valuations towards more defensive stocks with strong fundamentals. I also share my thoughts on the performance of the major banks and iron ore miners as well as some of the key stocks in IML’s portfolios including Brambles , Charter Hall Retail REIT , CSL  and Amcor .Lightly edited transcript – Recorded on 24 February. Jason Guthrie: Hello and welcome to Navigating the Noise, a podcast by Natixis Investment Managers, where we bring you insights from our global collective of experts to help you make better investment decisions. I’m Jason Guthrie, and today I’m joined by Michael O’Neill, portfolio manager on IML’s large cap team. Now, Mike has been with the firm for close to 15 years and co-manages a number of strategies, including the Equity Income Fund and also the Industrial Share Funds.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/large-cap-reporting-season-update-defensive-stocks-doing-well","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/large-cap-reporting-season-update-defensive-stocks-doing-well","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["LU1066051225.USD","LU1974910355.USD","LU1633808545.USD","LU2286300806.USD","LU1301847155.USD","BXB.AU","BK4598","LU1116320901.HKD","IE00BK4W5L77.USD","LU0265550946.USD","LU0109391861.USD","LU1066051498.USD","LU0234572021.USD","LU2111349929.HKD","AMC.AU","LU0823434740.USD","LU0320765059.SGD","LU1032466523.USD","LU2491049909.HKD","LU2491050071.SGD","LU2458330243.SGD","NAB.AU","IE00B4YYXB79.USD","SG9999014898.SGD","LU2552382215.SGD","IE00BMPRXR70.SGD","IE00BFSS7M15.SGD","LU1496350171.SGD","CSL.AU","LU1340139317.AUD","LU0308772762.SGD","LU1046421795.USD","SG9999002224.SGD","BHP.AU","LU2028103732.USD","LU2361044865.SGD","LU1778281490.HKD","WBC.AU","LU2065169927.USD","LU0314106906.USD","BK4579","CBA.AU","LU0289961442.SGD","CQR.AU","LU2720916845.USD","IE0004086264.USD","LU0289941410.SGD","IE00B5949003.HKD","LU0949170426.SGD"],"gpt_icon":1},{"id":"2514890782","title":"BRIEF-CSL Says Swissmedic Approves Andembry To Prevent Recurrent Attacks Of Hereditary Angioedema","url":"https://stock-news.laohu8.com/highlight/detail?id=2514890782","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514890782?lang=en_us&edition=fundamental","pubTime":"2025-02-27 08:41","pubTimestamp":1740616874,"startTime":"0","endTime":"0","summary":"BRIEF-CSL Says Swissmedic Approves Andembry To Prevent Recurrent Attacks Of Hereditary AngioedemaFeb 27  - CSL Ltd CSL.AX:SWISSMEDIC APPROVES CSL BEHRING'S ANDEMBRY  FOR PREVENTION OF RECURRENT ATTACKS OF HEREDITARY ANGIOEDEMAFurther company coverage: CSL.AX ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nFWN3PH1S3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7501","BK7508","CSL.AU","BK7511"],"gpt_icon":0},{"id":"2514886131","title":"CSL Ltd - Swissmedic Approves CSL Behring’s Andembry (Garadacimab) for Prevention of Recurrent Attacks of Hereditary Angioedema","url":"https://stock-news.laohu8.com/highlight/detail?id=2514886131","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514886131?lang=en_us&edition=fundamental","pubTime":"2025-02-27 03:14","pubTimestamp":1740597262,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nFWN3PH1S3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CSL.AU","BK7501","BK7511","BK7067","BK7508"],"gpt_icon":0},{"id":"2514080272","title":"CSL shares: Buy, sell or hold in 2025?","url":"https://stock-news.laohu8.com/highlight/detail?id=2514080272","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514080272?lang=en_us&edition=fundamental","pubTime":"2025-02-25 10:28","pubTimestamp":1740450494,"startTime":"0","endTime":"0","summary":"CSL Ltd  shares are up 0.3% at $261.87 today, shaking off the broader market sell-down. This sees the company with a market cap of almost $127 billion, making it the third largest stock on the ASX. Over the past year, however, shares in the S&P/ASX 200 Index biotech stock have trailed the benchmark, sliding 9%, while the ASX 200 has gained 8%. Though those losses were somewhat moderated by the $4.25 a share in unfranked dividends CSL paid out  over the year. But with CSL shares continuing to struggle in 2025, is the biotech stock one to buy, sell, or hold onto?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/02/25/csl-shares-buy-sell-or-hold-in-2025/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["LU0728928796.USD","XJO.AU","BK7067","BK7501","BK7508","CSL.AU","SGXZ23171101.USD","LU1169590202.USD","LU1169589451.USD","SG9999004303.SGD","BK4086","BK7511","CSL"],"gpt_icon":0},{"id":"2513324646","title":"3 super strong ASX 200 blue chip shares to buy for your SMSF","url":"https://stock-news.laohu8.com/highlight/detail?id=2513324646","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513324646?lang=en_us&edition=fundamental","pubTime":"2025-02-22 06:03","pubTimestamp":1740175438,"startTime":"0","endTime":"0","summary":"There are plenty of ASX 200 blue chip shares to choose from on the local share market for your self-managed super fund . But which ones could be buys?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/02/22/3-super-strong-asx-200-blue-chip-shares-to-buy-for-your-smsf/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["LU1868836757.USD","LU2237438978.USD","BK7067","IE0004086264.USD","BK4516","LU1791807156.HKD","LU2471134879.HKD","BK4127","IE00BSNM7G36.USD","BK4550","BK7511","LU2471134952.CNY","LU1868836591.USD","BK4588","IE00B64QTZ34.USD","LU2750360641.GBP","LU2750360997.AUD","IE0002270589.USD","LU1668664300.SGD","LU2237443382.USD","BK4533","IE0004091025.USD","LU0096364046.USD","LU1169590202.USD","LU2237443465.HKD","LU2237443549.SGD","LU1868837300.USD","LU1169589451.USD","BK7044","HAE","IE00BFXG1179.USD","LU0106261612.USD","LU0012050646.USD","BK4552","CSL.AU","IE00B19Z3581.USD","BK4198","LU2471134796.USD","BK4585","LU2237443622.USD","TWE.AU","LU2237443978.SGD","BK4504","LU0106831901.USD","LU0205193047.USD","LU2237443895.HKD","LU1868836914.USD","BKW.AU","BK7505","BK7508"],"gpt_icon":0},{"id":"2512482941","title":"Is Carlisle Companies Incorporated (NYSE:CSL) Trading At A 27% Discount?","url":"https://stock-news.laohu8.com/highlight/detail?id=2512482941","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512482941?lang=en_us&edition=fundamental","pubTime":"2025-02-19 22:25","pubTimestamp":1739975143,"startTime":"0","endTime":"0","summary":"Key Insights Using the 2 Stage Free Cash Flow to Equity, Carlisle Companies fair value estimate is US$484 Carlisle...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/3061000-choice1-main-header/1585186603448","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3061000-choice1-main-header/1585186603448"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/capital-goods/nyse-csl/carlisle-companies/news/is-carlisle-companies-incorporated-nysecsl-trading-at-a-27-d","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7511","CSL.AU","DCF","NYSE","LU0728928796.USD","FCF","BK4086","SGXZ23171101.USD","TV","LU1169589451.USD","CSL","SG9999004303.SGD","BK7508","LU1169590202.USD","BK4211","BK7501","BK4100","BK7067"],"gpt_icon":0},{"id":"2512189536","title":"This week’s Hot Stock tip is perfect way to pounce on RBA cut – but have an exit plan too","url":"https://stock-news.laohu8.com/highlight/detail?id=2512189536","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512189536?lang=en_us&edition=fundamental","pubTime":"2025-02-18 12:40","pubTimestamp":1739853600,"startTime":"0","endTime":"0","summary":"This week’s HotCopper Hot Stock from Wealth Within analystsFil Tortevskiand Pedro Banales is one of the simplest sells on the ASX – and “everyone knows about it” – because it leads the bourse: Commonwealth Bank .Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more.“The CBA has been the hot topic of recent weeks,” Mr Tortevski explained today.Importantly, the index leader is right in the middle of the rate cut storm coming through this week . “This bank is one of the biggest players there,” he added.Mr Tortevski explained it’s not a long hold though: “It’s a potential Hot Stock tip that has short-term potential… I’m not thinking long on CBA at all here, especially if we do go through another easing cycle shortly as well.”That warning proved prescient; CBA lost as much as 1.1% after the RBA’s Tuesday rate cut call, with much of the ASX dipping as it shaved value.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/this-weeks-hot-stock-tip-is-perfect-way-to-pounce-on-rba-cut-but-have-an-exit-plan-too-2025-02-18/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["BK7135","AMP.AU","CSL.AU","BK7511","BK7112","BK7508","BK7067","BK7501","CBA.AU"],"gpt_icon":0}],"pageSize":16,"totalPage":13,"pageCount":1,"totalSize":200}]}}